NCPDP Update. Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard. May 23, 2017

Similar documents
The Real-Time Benefit Check Key to Closing the Gaps in Eligibility Driven Formulary. Tony Schueth Chief Executive Officer & Managing Partner

NCPDP Electronic Prescribing Standards

Best Practice Recommendation for

Real-Time Pharmacy Benefit Inquiry: The Time is Right for More Informed Medication Decisions

Project: Surescripts Prescriptions Benefits - Eligibility & Formulary

Electronic Prior Authorization Initiatives at the Point of Care: Moving the Industry Forward

[F5] Leveraging Technology for Patient- Level Formulary & Benefit Information at the Point of Care

Community Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018

Employers Forum of Indiana and epa. March 23, 2016

2019 Transition Policy

Automating Specialty Pharmacy: Identifying Gaps

Prior Authorization between Prescribers and Processors for the Pharmacy Benefit

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Martin s Point Generations Advantage Policy and Procedure Form

Medicare Part D Transition Policy

NCPA summary of Part D Final Rule for contract year NCPA advocacy at work

MEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C

2018 Medicare Part D Transition Policy

Re: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of- Pocket Expenses [CMS-4180-P]

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

2018 Transition Fill Policy & Procedure. Policy Title: Issue Day: Effective Dates: 01/01/2018

Prime Perspective. From the auditor s desk. Quarterly Pharmacy Newsletter from Prime Therapeutics LLC. INSIDE From the auditor s desk...

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

1.1 PRIOR AUTHORIZATION INTRODUCTION

PEP-Portland Clinical Practices Policy Number: CP Policy Owner: Health Plan Operations Manager New Revised Reviewed

Supplemental Payer Transactions (Nx) Part D Plan Nx Performance Reports Guide Effective

1 INSURANCE SECTION Instructions: This section contains information about the cardholder and their plan identification.

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy

Harvard Pilgrim Health Care Pharmacy Services Policy & Criteria. Medicare Advantage Transition of Care

PURPOSE OF THE POLICY STATEMENT OF THE POLICY PROCEDURES

Life Journey of a Claim

PHARMACY BENEFIT MANAGEMENT (PBM) SERVICES

Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D

2012 Checklist for Community Pharmacy. Medicare Part D-Related Information

Medicare Advantage Part D Pharmacy Policy

National Council for Prescription Drug Programs

2012 Medicare Part D Transition Process for contracts H3864 & H4754:

Prescription Drug Plan Update

Pharmacy/Prescriber Medicaid Managed Care Network & Medicaid Provider Enrollment. February 14, 2018

Network Pharmacy Weekly

Pharmacy Benefit Managers Overview

Subject: Indiana Health Coverage Programs (IHCP) Transition to the National Council for Prescription Drug Programs (NCPDP) Version 5.

Magellan Complete Care of Virginia (MCC of VA) Provider Training. July 2017

SecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals

Upstream Reporting of Copay Assistance Issues Brief

Medicare Transition POLICY AND PROCEDURES

Kaiser Permanente Northern California KPNC

CIS Responses to Vendor Questions PBM RFP September 23, 2015 Addendum #1

Coverage Determinations, Appeals and Grievances

Values Accountability Integrity Service Excellence Innovation Collaboration

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

From the auditor s desk. Billing compounds as single-ingredient claims. Submit Compound Prescription with a code of 2 in the Compound Code field.

Integrated Prescription Management (IPM)/ PharmAvail Benefit Management Payor Specification Sheet

Subject: Pharmacy Services & Formulary Management (Page 1 of 5)

The Real Deal About Real-Time Benefits. Proven Savings with Up-to-the-Minute, Member-Specific Information Across Multiple Points of Care

Regulatory/Legislative Update

MAINE GENERAL ASSISTANCE NCPDP VERSION D.Ø PAYER SHEET

NCPDP Version 5 Request Payer Sheet

2019 Transition Policy and Procedure

Understanding Your Prescription Program. CCIU Employee Meeting September 7, 2016

Prime Perspective. From the auditor s desk. Quarterly Pharmacy Newsletter from Prime Therapeutics LLC INSIDE. September 2018: Issue 73

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards

TRANSITION POLICY. Members Health Insurance Company

BlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals

Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy

Texas Vendor Drug Program Pharmacy Provider Procedure Manual

Payer Specification Sheet For Prime Therapeutics BCBS of Texas CHIP, STAR and STAR KIDS Medicaid Programs

UC SHIP Premium Formulary. Effective September 1, 2016

Medicare s s 2009 eprescribing Program

Pharmacy Billing and Reimbursement

1. NCPDP VERSION D.0 CLAIM BILLING 1.1 REQUEST CLAIM BILLING

Prime Perspective. From the auditor s desk. Quarterly Pharmacy Newsletter from Prime Therapeutics LLC INSIDE. March 2019: Issue 75

Get the most out of your pharmacy benefit.

Pharmacy Benefit Management in Oncology

Prescription Drug Services

Prescriber Web Prior Authorization

Pharmacy Network Providers Manual

Chapter 17: Pharmacy and Drug Formulary

Telecommunications Standard JULY 2012

Pharmaceutical Management Medicaid 2018

Part D Request Claim Billing/Claim Rebill Test Data

Supporting Appropriate Payer Coverage Decisions

Electronic Prior Authorization (epa): Technology Advances and Emerging Legislative Requirements

NCPDP VERSION 5.1 REQUEST PAYER SHEET

Classification: Clinical Department Policy Number: Subject: Medicare Part D General Transition

Medicare Part D Transition IHM Departmental Policy

Putting the Pieces Together, a Review of the Benefits Investigation Process. Thomas Cohn, Asembia

Healthcare Services (HCS) Integrated Health Management (IHM) Departmental Policy MEDICARE PART D TRANSITION

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards

CDHP Special Administration

emedny Prospective Drug Utilization Review/ Electronic Claim Capture and Adjudication ProDUR/ECCA Standards

REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax:

OTHER TRANSACTIONS SUPPORTED Payer: Please list each transaction supported with the segments, fields, and pertinent information on each transaction.

Y0076_ALL Trans Pol

SPECIALTY PHARMACY ACCREDITATION V3.0 MANDATORY MEASURES

Pharmaceutical Management Community Plans 2018

Prescription Drug Coverage

Payer Specification Sheet for Prime Therapeutics Medicare Part D Supplemental Clients

Real-Time Benefit Check (RTBC) Solution Assessment. Requirements for selecting the most valuable RTBC solution for your health system

21 - Pharmacy Services

Transcription:

NCPDP Update Review of NCPDP Task Group Efforts and Use Cases for Real-Time Benefit Inquiry Standard May 23, 2017

Catherine C Graeff CEO, Sonora Advisory Group, LLC Active in NCPDP since 1988 - as a member, leader, trustee and staff Member of NCPDP Real-Time Prescription Benefit (RTPB) Task Group since May 2014

About NCPDP ANSI-accredited SDO About 1500 members representing 3 major categories of pharmacy services industry Developed national standards named in HIPAA, MMA, other regulations Over 75 Task Groups reporting to 10 Work Groups Develop Standards & Implementation Guides, Guidance, White Papers, etc. After standards are balloted and pass, are approved by ANSI

Presentation Overview Define RTPB Task Group Scope Overview of Initial Use Cases (v1.0) Other Considerations Timeline Q&A

Real-Time Prescription Benefit Inquiry Task Group Formed in May 2014 due to CMS and industry discussions Identified need for an industry-wide standard solution ONC requested comments as part of the EHR Certification rulemaking process Identified use cases associated with a prescription benefit inquiry Surveyed industry organizations to understand the priority of each use case identified Delivered Business Requirements (use case document, data requirements), not the standard itself in February 2017

What Is Today s Problem? The prescriber may not know: If the medication is on-formulary for the patient. If there are any utilization edits (i.e. prior auth., quantity limits). If the patient s cost-share is manageable for the patient. If the patient s choice of pharmacy will impact their cost-share. If the patient is taking a medication that may cause an adverse event. Today s other standards such as the Formulary & Benefit Standard does not provide detailed, patientspecific benefit information.

What is a Real-Time Prescription Benefit (RTPB) Request/Response Transaction? A means to provide patient-specific prescription benefit information at the point-of-care Request for prescription benefit information originating from the provider (prescriber) Processor/PBM/Adjudicator provides the response to the request Response represents status at the point-in-time the request was processes

Benefits of RTPB Request & Response Facilitates provider and patient decisions on the most appropriate covered drug pharmacy selection the estimated patient cost of therapy Reduces rejected claims at point of dispensing Reducing pharmacy, PBM, provider and patient interaction for benefit related reasons Anticipate improvement in medication adherence

RTPB Standard Participants and Flow Provider Data Capture UI Display Request Request EHR/EMR Intermed. Switch (Routing) Processor PBM Adjudicator Response Response

Structure of Requests and Responses Each Request and each Response is made up of combined fields or Segments. Segments are Required or Optional, depending upon the Use Case triggered in forming the Response Each Segment is made up of Fields Fields are Required or Situational, depending upon the Use Case triggered in forming the Response Multiple Use Cases can be triggered in a single response by the Payer/PBM Sonora Advisory Group, LLC 2017 10

Examples of Segments and Fields Patient Information Prescription Information Pharmacy Information Provider Information Patient Name fields Product ID Pharmacy ID Prescriber ID Date of Birth Quantity Gender Unit of Measure Member ID Days Supply 11

Other Segments Used In Request or Responses Routing Information (always required) Transaction Information (always required) Additional Information Financial Information Coverage Limits Reject/Denial Explanation (required in all but Use Case 1) Drug Utilization Evaluation For each Use Case, Segments are Required or Optional and Data Elements within that Segment are Required or Situational Sonora Advisory Group, LLC 2017 12

What is a Use Case? The Task Group used the term Use Case to describe the most common benefit scenarios, and the fields that are necessary in the Request to allow the PBM to process the request; the fields that are necessary in the Response to provide the Provider/EHR System and Patient with the information necessary to understand the patient s benefit at that point in time, and to take appropriate action in. Sonora Advisory Group, LLC 2017 13

High Priority Use Cases (scenarios) 1. Patient Eligible, Product Covered 2. Patient Not Eligible 3. Benefit Exclusion 4. Formulary Exclusion 5. Coverage Limits 6. Step Therapy Required 7. Prior Authorization Required 8. Out of Network Pharmacy 9. Out of Network Provider 10. Patient/Provider Lock-In 11. Patient DUE Alert 12. Restricted Pharmacy

If multiple Use Cases Apply, all required information will be returned in a single Response Provider Data Capture UI Display EHR/EMR Request Response Intermed. Switch (Routing) Request Response Processor PBM Adjudicato r

What is the Use Case Document? Captures the business requirements for the development of the initial RTPB Standard for the 12 Initial Use Cases Describes the Request and Response process and scenarios under which a PBM sends a Response Identifies data to be included in the Request and in the Response for each use case Completed and delivered by the Task Group to NCPDP Maintenance & Control February 2017 for approval

All Request Transactions Require the Following Segments of Information: Routing/Payer Information Transaction specific Information Patient Information Prescription Information Pharmacy Information Provider Information

Two Types of Responses Affirmative Use Case 1: Patient and Drug are covered. Negative Use Cases 2-12: Some issue with the patient, benefit, product, pharmacy, or prescriber that should be communicated to the provider and patient Sonora Advisory Group, LLC 2017 18

Affirmative Responses (Use Case 1) Requires the Following Segments: Routing Information Transaction-specific Information Prescription Information (as submitted) Financial (Estimated Patient Financial Responsibility Any additional segments are optional. Some data elements within a segment may be situational

Negative Responses Require the Following Segments: Routing Information Transaction-specific Information Reject/Denial Explanation Prescription Information (as submitted) Any additional Segments are Required or Optional, dependent upon the Use Case. Some data elements within a segment may be situational

Other Task Group Considerations In Scope Patient-specific drug benefit info Identify information in provider request Identify information in Processor/PBM/Adjudicator response to request Product alternatives Real-time communication Out of Scope RTPB requests from anyone other than prescribers Payer/PBM s cost of the product Subscriber identification Coordination of Benefits Requests for services, partial fills, compounded prescriptions

Use Case 1: Patient Eligible, Product Covered A provider submits a request, it is routed to the Processor/PBM/Adjudicator who processes the request, and sends an affirmative response to the provider. There are no issues with this benefit inquiry.

Use Case 1: Patient Eligible, Product Covered Mary Smith sees Dr. Jones, who determines she needs a beta blocker. Dr. Jones selects #30 Bystolic, Elm Street Pharmacy and submits the benefit request. Mary s plan responds with a message that Bystolic is covered and that Mary s copay will be $20 for a 30 day supply at Elm Street Pharmacy.

Use Case 1: Patient Eligible, Product Covered Provider Data Capture EHR/EMR UI Display Request Affirmative Response (Financial Responsibility) Intermediary/ Switch (Routing) Affirmative Request Response (Financial Responsibility) Processor/PBM/ Adjudicator

Use Case 2: Patient Not Eligible A provider submits a request, it is routed to the Payer/PBM who processes the request, and sends an negative response to the provider. The patient is not eligible for pharmacy benefits on the day the request was received.

Use Case 2: Patient Not Eligible Provider Data Capture EHR/EMR UI Display Request Negative Intermediary /Switch (Routing) Request Negative Processor/PBM /Adjudicator Response (Patient Not Eligible) Response (Patient Not Eligible)

Use Case 3: Benefit Exclusion A provider submits a request, it is routed to the Payer/PBM who processes the request, and sends an negative response to the provider. The product requested for the patient is excluded from coverage under the patient s benefit plan. No alternatives are available.

Use Case 3: Benefit Exclusion Example John Smith sees Dr. Nelson and asks about medicine to treat his erectile dysfunction. Dr. Nelson submits a benefit request for sildenafil. John s plan responds that sildenafil is excluded from coverage under John s plan. John needs to decide if he wants to pay cash for this prescription.

Use Case 4: Formulary Exclusion A provider submits a request, it is routed to the Payer/PBM who processes the request, and sends an negative response to the provider. The product requested for the patient is excluded from the patient s formulary. If there are formulary alternatives, up to ten (10) alternative products, and the associated Estimated Patient Financial Responsibility, may be identified on the response.

Use Case 4: Formulary Exclusion Example Bob Harrison sees Dr. Maple. Dr. Maple determines that Bob needs to begin statin treatment. Dr. Maple submits a request for Lescol, 30 day supply at Big Box Pharmacy. Bob s plan responds that Lescol is not on formulary, but that atorvastatin, fluvastatin and lovastatin are all preferred formulary products. Bob will pay $10 for a 30 day supply of either formulary product at Big Box Pharmacy. Bob could also pay $20 for a 90 day supply at Big Box or through the plan s mail order pharmacy.

Use Case 5: Coverage Limits The product is covered, but a component of the request is not covered for the by the plan for the patient. The plan has a limit on the quantity or days supply allowed, or the patient s age and/or gender may not be clinically appropriate for the requested medication.

Use Case 6: Step Therapy Required The product may be covered/approved if Step Therapy Requirements are fulfilled. The plan may require that other medications be tried before the requested medication is approved for coverage. Estimated Patient Financial Responsibility, if provided, is what the patient is expected to pay if edit resolved. Alternative products may be provided

Use Case 7: Prior Authorization Required The submitted product requires a prior authorization The patient financial responsibility, if returned, is what the patient is expected to pay if the PA is approved The may return up to 10 alternative products

Other Use Cases Use Case 8: Out-of-Network Pharmacy The requested pharmacy is not in the plan s network and the patient will have to pay cash if they choose to use that pharmacy. Use Case 9: Out-of-Network Provider The provider on the request is not in the plan s network and the patient may have to pay cash if they choose to use that provider. Use Case 10: Patient/Provider Lock-In The patient is restricted to a specific provider(s) and the plan will not pay for prescriptions written by the requesting provider.

Other Use Cases, continued Use Case 11: Drug Utilization Evaluation (DUE) Alert The plan has information about a medication that the patient appears to be currently taking that is causing a utilization alert severe enough that a claim for the requested product will be rejected at the pharmacy. Limit of 5 specific DUE/DUR alerts Use Case 12: Restricted Pharmacy The drug is covered, but the pharmacy identified in the request is not eligible to fill the product for the patient. Occurs when the patient is locked-in to a specific pharmacy or must obtain the product through a mail order or specialty pharmacy(ies).

NCPDP Timeline NCPDP approved Use Case Document and related data requirements at NCPDP Work Group meetings in February 2017 At Work Group meetings in May 2017, a new Task Group formed to address the creation of a single standard supported by both Telecom and SCRIPT syntaxes June 2017 - Standard development activities commence as with all NCPDP standards

When Will the Standard Be Completed? New Task Group will use approved Use Case Document and data requirements to develop the standard in the 2 syntaxes Three year effort to provide this documentation and will streamline efforts Standard will be presented at a future NCPDP Work Group meeting for approval (1 st or 2 nd quarter 2018?) If approved, standard will be balloted during a spring or fall NCPDP ballots voted upon by the NCPDP consensus group. If approved, new standard will go through NCPDP internal processes and obtain ANSI approval Sonora Advisory Group, LLC 2017 37

Questions? Sonora Advisory Group, LLC 2017 38